A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease
Clinical trial NCT00287742 · TERMINATED
Trial details
- NCT number
- NCT00287742
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.